Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Kidney International|July 1, 1980
Plasma protein binding in uremia: extraction and characterization of an inhibitorT A Depner, P F GulyassyJournal of Chromatography|December 22, 1976
Comparison of batch and chromatographic assays of cyclic nucleiotide phosphodiesterasesP F Gulyassy, J R FarrandAmerican Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 1, 1984
Inhibition of salicylate binding to normal plasma by extracts of uremic fluidsS Roman, P F Gulyassy, T A DepnerBiochemical Pharmacology|December 15, 1987
Contributions of hippurate, indoxyl sulfate, and o-hydroxyhippurate to impaired ligand binding by plasma in azotemic humansP F Gulyassy, E Jarrard, L A StanfelClinical Chemistry|February 1, 1981
Four methods for determining albumin in azotemic sera evaluatedP F Gulyassy, T A Depner, W K MaClinical Chemistry|June 1, 1986
Determination of indoxyl sulfate in plasma of patients with renal failure by use of ion-pairing liquid chromatographyL A Stanfel, P F Gulyassy, E A JarrardKidney International|November 1, 1975
Multiple cyclic nucleotide phosphodiesterases in rat kidneyP F Gulyassy, J R Farrand, H D GuglerASAIO Journal (American Society for Artificial Internal Organs : 1992)|July 1, 1993
Comparison of binding by concentrated peritoneal dialysate and serumP F Gulyassy, T A Depner, G C ShearerNephron|January 1, 1980
Impaired plasma phenytoin binding in uremia. Effect of in vitro acidification and anion-exchange resinT A Depner, L A Stanfel, E A Jarrard, et al.Kidney International. Supplement|December 1, 1983
Isolation of inhibitors of ligand: albumin-binding from uremic body fluids and normal urineP F Gulyassy, A T Bottini, E A Jarrard, et al.Pageof 2